BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33175453)

  • 1. Salvage living donor liver transplantation for hepatocellular carcinoma recurrence after hepatectomy: Quantitative prediction using ADV score.
    Hwang S; Song GW; Ahn CS; Kim KH; Moon DB; Ha TY; Jung DH; Park GC; Yoon YI; Lee SG
    J Hepatobiliary Pancreat Sci; 2021 Nov; 28(11):1000-1013. PubMed ID: 33175453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Prognostic Prediction Using ADV Score for Hepatocellular Carcinoma Following Living Donor Liver Transplantation.
    Hwang S; Song GW; Ahn CS; Kim KH; Moon DB; Ha TY; Jung DH; Park GC; Yoon YI; Lee SG
    J Gastrointest Surg; 2021 Oct; 25(10):2503-2515. PubMed ID: 33532981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantation.
    Yamashita Y; Yoshida Y; Kurihara T; Itoh S; Harimoto N; Ikegami T; Yoshizumi T; Uchiyama H; Shirabe K; Maehara Y
    Liver Transpl; 2015 Jul; 21(7):961-8. PubMed ID: 25772591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Prediction of Posttransplant Hepatocellular Carcinoma Prognosis Using ADV Score: Validation with Korea-Nationwide Transplantation Registry Database.
    Park GC; Hwang S; You YK; Choi Y; Kim JM; Joo DJ; Ryu JH; Choi D; Kim BW; Kim DS; Nah YW; Kang KJ; Cho JY; Yu HC; Kim DG
    J Gastrointest Surg; 2023 Jul; 27(7):1353-1366. PubMed ID: 37039979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma.
    Hwang S; Lee SG; Moon DB; Ahn CS; Kim KH; Lee YJ; Ha TY; Song GW
    Liver Transpl; 2007 May; 13(5):741-6. PubMed ID: 17457860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Feasibility of Salvage Living Donor Liver Transplantation after Initial Liver Resection in Patients with Hepatocellular Carcinoma.
    Abe T; Tashiro H; Teraoka Y; Hattori M; Tanimine N; Kuroda S; Tahara H; Ohira M; Tanaka Y; Kobayashi T; Ide K; Ishiyama K; Ohdan H
    Dig Surg; 2016; 33(1):8-14. PubMed ID: 26551258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
    Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
    World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of des-γ-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma.
    Harimoto N; Yoshida Y; Kurihara T; Takeishi K; Itoh S; Harada N; Tsujita E; Yamashita YI; Uchiyama H; Soejima Y; Ikegami T; Yoshizumi T; Kawanaka H; Ikeda T; Shirabe K; Saeki H; Oki E; Kimura Y; Maehara Y
    Transplant Proc; 2015 Apr; 47(3):703-4. PubMed ID: 25819732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage living donor liver transplantation versus repeat liver resection for patients with recurrent hepatocellular carcinoma and Child-Pugh class A liver cirrhosis: A propensity score-matched comparison.
    Yoon YI; Song GW; Lee S; Moon D; Hwang S; Kang WH; Cho HD; Ha SM; Kim MJ; Kim SH; Na BG; Yang G; Min Kim S; Hyun Shim J; Park JI
    Am J Transplant; 2022 Jan; 22(1):165-176. PubMed ID: 34383368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
    Lee EC; Kim SH; Shim JR; Park SJ
    Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.
    Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK
    Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
    J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
    Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
    J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Living Donor Liver Transplantation.
    Yang G; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Yoon YI; Kang WH; Joo SH; Lee SG
    Ann Transplant; 2024 Mar; 29():e942767. PubMed ID: 38439530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The surgical challenges of salvage living donor liver transplantation for Hepatocellular carcinoma; The cumulative experience of 100 cases - A retrospective cohort study and a propensity score analysis.
    Yong CC; Elsarawy AM; Wang SH; Lin TS; Wang CC; Li WF; Lin TL; Kuo FY; Cheng YF; Chen CL; Lin CC
    Int J Surg; 2018 Jun; 54(Pt A):187-192. PubMed ID: 29723674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis.
    Lim C; Shinkawa H; Hasegawa K; Bhangui P; Salloum C; Gomez Gavara C; Lahat E; Omichi K; Arita J; Sakamoto Y; Compagnon P; Feray C; Kokudo N; Azoulay D
    Liver Transpl; 2017 Dec; 23(12):1553-1563. PubMed ID: 28945955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 20. Salvage liver transplantation for recurrent hepatocellular carcinoma within UCSF criteria after liver resection.
    Liu F; Wei Y; Wang W; Chen K; Yan L; Wen T; Zhao J; Xu M; Li B
    PLoS One; 2012; 7(11):e48932. PubMed ID: 23145027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.